Effect of superfine grinding on antidiabetic activity of bitter melon powder

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 14203-14218

  Zhu, Ying ^a   Dong, Ying ^a   Qian, Xiwen ^a   Cui, Fengjie ^a   Guo, Qin ^a   Zhou, Xinghua ^a   Wang, Yun ^a   Zhang, Yi ^a   Xiong, Zhiyu ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Anti diabetic activity; Bitter melon powder; Diabetes; Food processing; Superfine grinding

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FLAVONOID; GLUCOSE; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; POLYPHENOL; SAPONIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLUTATHIONE; LIPID; POWDER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; FLUID INTAKE; FOOD INTAKE; FREEZE DRYING; GLUCOSE BLOOD LEVEL; GRINDING; HISTOPATHOLOGY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALE; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; RAT; STREPTOZOCIN DIABETES; SUPERFINE GRINDING; TEMPERATURE SENSITIVITY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PANCREAS; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; MOMORDICA CHARANTIA; PANCREAS; PARTICLE SIZE; POWDERS; RATS; SUPEROXIDE DISMUTASE;

EID: 84870672366     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131114203     Document Type: Article

References (56)

1. Li, M.; Chen, Y.; Liu, Z.; Shen, F.; Bian, X.; Meng, Y. Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol. Acta Biochim. Biophys. Sin. 2009, 41, 792-799.
2. Fang, E.F.; Ng, T.B. Bitter gourd (Momordica charantia) is a cornucopia of health: A review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr. Mol. Med. 2011, 11, 417-436.
3. Nerurkar, P.; Ray, R.B. Bitter melon: Antagonist to cancer. Pharm. Res. 2010, 27, 1049-1053.
4. Lii, C.K.; Chen, H.W.; Yun, W.T.; Liu, K.L. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW 264.7 macrophages. J. Ethnopharmacol. 2009, 122, 227-233.
5. Kubola, J.; Siriamornpun, S. Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro. Food Chem. 2008, 110, 881-890.
6. Wu, S.J.; Ng, L.T. Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. LWT-Food Sci. Technol. 2008, 41, 323-330.
7. Braca, A.; Siciliano, T.; D'Arrigo, M.; Germanò, M.P. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia 2008, 79, 123-125.
8. Mwambete, K. The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: A Tanzania medicinal plant. Afr. Health Sci. 2009, 9, 34-39.
9. Miura, T.; Itoh, C.; Iwamoto, N.; Kato, M.; Kawai, M.; Park, S.R.; Suzuki, I. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutr. Sci. Vitaminol. 2001, 47, 340-344.
10. Reyes, B.A.S.; Bautista, N.D.; Tanquilut, N.C.; Anunciado, R.V.; Leung, A.B.; Sanchez, G.C.; Magtoto, R.L.; Castronuevo, P.; Tsukamura, H.; Maeda, K.I. Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. J. Ethnopharmacol. 2006, 105, 196-200.
11. Krawinkel, M.B.; Keding, G.B. Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr. Rev. 2006, 64, 331-337.
12. Jayasooriya, A.P.; Sakono, M.; Yukizaki, C.; Kawano, M.; Yamamoto, K.; Fukuda, N. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J. Ethnopharmacol. 2000, 72, 331-336.
13. Ahmed, I.; Lakhani, M.S.; Gillett, M.; John, A.; Raza, H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordicacharantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 2001, 51, 155-161.
14. Grover, J.; Yadav, S. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 2004, 93, 123-132.
15. Karunanayake, E.H.; Tennekoon, K.H. Search of novel hypoglycemic agents from medicinal plants. In Diabetes Mellitus and Its Complications, An Update; Sharma, A.K., Ed.; Macmillan India Ltd.: New Delhi, India, 1993; pp. 192-205.
16. Islam, S.; Jalaluddin, M.; Hettiarachchy, N.S. Bio-active compounds of bitter melon genotypes (Momordica charantia L.) in relation to their physiological functions. Funct. Foods Health Dis. 2011, 2, 61-74.
17. Akhtar, M.S.; Athar, M.A.; Yaqub, M. Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits. Planta Med. 1981, 42, 205-212.
18. Kar, A.; Choudhary, B.; Bandyopadhyay, N. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol. 2003, 84, 105-108.
19. Fuangchan, A.; Sonthisombat, P.; Seubnukarn, T.; Chanouan, R.; Chotchaisuwat, P.; Sirigulsatien, V.; Ingkaninan, K.; Plianbangchang, P.; Haines, S.T. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J. Ethnopharmacol. 2011, 134, 422-428.
20. Shih, C.-C.; Lin, C.-H.; Lin, W.-L.; Wu, J.-B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J. Ethnopharmacol. 2009, 123, 82-90.
21. Raman, A.; Lau, C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 1996, 2, 349-362.
22. Yibchok, S.; Adisakwattana, S.; Cheng, Y.Y.; Sangvanich, P.; Roengsumran, S.; Hsu, W.H. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol. Pharm. Bull. 2006, 29, 1126-1131.
23. Chen, Q.; Chan, L.L.Y.; Li, E.T.S. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J. Nutr. 2003, 133, 1088-1093.
24. Senanayake, G.V.K.; Maruyama, M.; Shibuya, K.; Sakono, M.; Fukuda, N.; Morishita, T.; Yukizaki, C.; Kawano, M.; Ohta, H. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J. Ethnopharmacol. 2004, 91, 257-262.
25. Ahmed, I.; Adeghate, E.; Sharma, A.K.; Pallot, D.J.; Singh, J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res. Clin. Pract. 1998, 40, 145-151.
26. Kumar, R.; Balaji, S.; Uma, T.S.; Sehgal, P.K. Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPARγ and PI3K. J. Ethnopharmacol. 2009, 126, 533-537.
27. Nerurkar, P.V.; Lee, Y.K.; Motosue, M.; Adeli, K.; Nerurkar, V.R. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br. J. Nutr. 2008, 100, 751-759.
28. Sridhar, M.; Vinayagamoorthi, R.; Arul Suyambunathan, V.; Bobby, Z.; Selvaraj, N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br. J. Nutr. 2008, 99, 806-812.
29. Tkacova, K.; Stevulova, N. Selected problems of the dispersity analysis of milled ultrafine powders. Freiberger Forsch. A (Partik.) 1998, A841, 14-25.
30. Wu, G.; Zhang, M.; Wang, Y.; Mothibe, K.J.; Chen, W. Production of silver carp bone powder using superfine grinding technology: Suitable production parameters and its properties. J. Food Eng. 2012, 109, 730-735.
31. Zhao, X.; Du, F.; Zhu, Q.; Qiu, D.; Yin, W.; Ao, Q. Effect of superfine pulverization on properties of Astragalus membranaceus powder. Powder Technol. 2010, 203, 620-625.
32. Zhao, X.-Y.; Ao, Q.; Yang, L.-W.; Yang, Y.-F.; Sun, J.-C.; Gai, G.-S. Application of superfine pulverization technology in Biomaterial Industry. J. Taiwan Inst. Chem. Eng. 2009, 40, 337-343.
33. Maaroufi, C.; Melcion, J.; de Monredon, F.; Giboulot, B.; Guibert, D.; Le Guen, M.P. Fractionation of pea flour with pilot scale sieving. I. Physical and chemical characteristics of pea seed fractions. Anim. Feed Sci. Technol. 2000, 85, 61-78.
34. Sakata, Y.; Shiraishi, S.; Otsuka, M. Effect of pulverization of the bulk powder on the hydration of creatine anhydrate tablets and their pharmaceutical properties. Colloids Surf. B Biointerfaces 2005, 46, 92-100.
35. Zhu, K.; Huang, S.; Peng, W.; Qian, H.; Zhou, H. Effect of ultrafine grinding on hydration and antioxidant properties of wheat bran dietary fiber. Food Res. Int. 2010, 43, 943-948.
36. Hu, J.; Chen, Y.; Ni, D. Effect of superfine grinding on quality and antioxidant property of fine green tea powders. LWT-Food Sci. Technol. 2012, 45, 8-12.
37. Król, E.; Krejpcio, Z. Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem. Toxicol. 2011, 49, 3217-3223.
38. Sahin, K.; Onderci, M.; Tuzcu, M.; Ustundag, B.; Cikim, G.; Ozercan, İ.H.; Sriramoju, V.; Juturu, V.; Komorowski, J.R. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat. Metabolism 2007, 56, 1233-1240.
39. Zheng, X.-K.; Zhang, L.; Wang, W.-W.; Wu, Y.-Y.; Zhang, Q.-B.; Feng, W.-S. Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ. J. Ethnopharmacol. 2011, 137, 662-668.
40. Shih, C.-C.; Lin, C.-H.; Lin, W.-L. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res. Clin. Pract. 2008, 81, 134-143.
41. Kang, J.S.; Lee, W.K.; Lee, C.W.; Yoon, W.K.; Kim, N.; Park, S.-K.; Lee, H.-S.; Park, H.K.; Han, S.-B.; Yun, J.; et al. Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and l-carnitine: Implications in cardiovascular and non-alcoholic fatty liver diseases. Food Chem. Toxicol. 2011, 49, 2453-2458.
42. Mythili, M.D.; Vyas, R.; Akila, G.; Gunasekaran, S. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc. Res. Tech. 2004, 63, 274-281.
43. Srinivasan, K.; Viswanad, B.; Asrat, L.; Kaul, C.L.; Ramarao, P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 2005, 52, 313-320.
44. Kasbia, G.S.; Arnason, J.T.; Imbeault, P. No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: A pilot study in non-diabetic overweight men. J. Ethnopharmacol. 2009, 126, 127-133.
45. Kirpichnikov, D.; McFarlane, S.I.; Sowers, J.R. Metformin: An update. Ann. Intern. Med. 2002, 137, 25-33.
46. Collier, C.A.; Bruce, C.R.; Smith, A.C.; Lopaschuk, G.; Dyck, D.J. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am. J. Physiol. Endocrinol. Metabol. 2006, 291, E182-E189.
47. Kunyanga, C.N.; Imungi, J.K.; Okoth, M.W.; Biesalski, H.K.; Vadivel, V. Total phenolic content, antioxidant and antidiabetic properties of methanolic extract of raw and traditionally processed Kenyan indigenous food ingredients. LWT-Food Sci. Technol. 2012, 45, 269-276.
48. Keller, A.C.; Ma, J.; Kavalier, A.; He, K.; Brillantes, A.M.B.; Kennelly, E.J. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 2011, 19, 32-37.
49. Palumbo, P. Metformin: Effects on CardiovascularRisk Factors in Patients with Non-Insulin-Dependent Diabetes Mellitus. J. Diabetes Complicat. 1998, 12, 110-119.
50. Zhang, M.; Zhang, C.-J.; Shrestha, S. Study on the preparation technology of superfine ground powder of Agrocybe chaxingu Huang. J. Food Eng. 2005, 67, 333-337.
51. Popovich, D.G.; Li, L.; Zhang, W. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells. Food Chem. Toxicol. 2010, 48, 1619-1626.
52. Masiello, P. Animal models of type 2 diabetes with reduced pancreatic β-cell mass. Int. J. Biochem. Cell Biol. 2006, 38, 873-893.
53. Pinent, M.; Castell, A.; Baiges, I.; Montagut, G.; Arola, L.; Ardévol, A. Bioactivity of Flavonoids on Insulin-Secreting Cells. Compr. Rev. Food Sci. Food Saf. 2008, 7, 299-308.
54. Ishii, Y.; Ohta, T.; Sasase, T.; Morinaga, H.; Hata, T.; Miyajima, K.; Katusda, Y.; Masuyama, T.; Shinohara, M.; Kakutani, M.; et al. A high-fat diet inhibits the progression of diabetes mellitus in type 2 diabetic rats. Nutr. Res. 2010, 30, 483-491.
55. Zhao, X.; Yang, Z.; Gai, G.; Yang, Y. Effect of superfine grinding on properties of ginger powder. J. Food Eng. 2009, 91, 217-222.
56. Xu, B.; Dong, Y. Determination on Total Saponins of Momordica Charantia L. by Spectrophotometry. Food Sci. 2005, 10, 165-169.